From pathophysiology to treatment of monogenic diseases (5)

Gene therapy: some clinical trials in preparation. (Huntington's and dystrophic myotonia, metachromatic leukodystrophy, Leber's optic atrophy). Mutation-specific pharmacological therapies: nonsense mutation suppressors, chaperones.